AVERAGE BIOEQUIVALENCE INNOVATIONS SL
Hoja M722544· NIF B88623665
- Registered address :
- Activity :
- Investigación y desarrollo experimental en biotecnología
- Legal form :
- Sociedad Limitada (SL)
- Share capital :
- 3 000,00 €
- Incorporation :
- 27/07/2020
- Director :
- Corredera Hernandez Francisco Javier
Legal information
Legal information for AVERAGE BIOEQUIVALENCE INNOVATIONS SL
Activity
AVERAGE BIOEQUIVALENCE INNOVATIONS SL is a Sociedad Limitada (SL) with its registered office in Madrid. Its declared activity is “Investigación y desarrollo experimental en biotecnología” (CNAE 7211). It was incorporated on 27 July 2020. The Spanish commercial register has published 3 filings for this company, across 3 distinct types of filing. Its registered share capital is 3 000,00 €.
Economic activity (CNAE)
7211 · Investigación y desarrollo experimental en biotecnología
Corporate purpose
Investigación y desarrollo experimental en biotecnología; evaluación y estudio, previo y posterior, de bioequivalencia y farmacocinética de todo tipo de productos farmacéuticos presentados por las compañías farmacéuticas, así como la asesoría en las fases de desarrollo de estos productos".
Directors and representatives
Directors
Current
- Corredera Hernandez Francisco JavierSince 20/07/2020Administrador Único
Directors network map
Cap table · shareholdings
Individual · since 27/07/2020 · socio único (BORME)
Shareholders network map
Beneficial owner (UBO)
Corredera Hernandez Maria Teresa100 %
Individual · ultimate beneficial owner · since 27/07/2020
Beneficial owner network map
Registered actos
- ConstituciónPublished 27/07/2020· Registered 20/07/2020· I/A 1
- Declaración de unipersonalidadPublished 27/07/2020· Registered 20/07/2020· I/A 1
- NombramientosPublished 27/07/2020· Registered 20/07/2020· I/A 1
Changes
- 27/07/2020Declaración de unipersonalidad
CORREDERA HERNANDEZ MARIA TERESA
Capital · events
- 27/07/2020ConstituciónInitial capital: 3 000,00 €
Importes obtenidos del BORME cuando se publican (importe de la operación y capital resultante). Algunos anuncios no lo publican; en ese caso consulte el PDF original.
Timeline (BORME)
- 27/07/2020#5967362ConstituciónDeclaración de unipersonalidadNombramientos
AVERAGE BIOEQUIVALENCE INNOVATIONS SL. Constitución. Comienzo de operaciones: 13.03.20. Objeto social: "Investigación y desarrollo experimental en biotecnología; evaluación y estudio, previo y posterior, de bioequivalencia y farmacocinética de todo t…
Official documents
Official Registro Mercantil documents that we obtain and deliver to you as PDFs.
Nota informativa mercantil (company extract)
Current registry status: administradores and apoderados with their DNI, objects, capital, registered address and latest accounts filing.
Public
Filed annual accounts
Actual image of the filing for each financial year: balance sheet, profit and loss account and shareholder structure.
Public
Certified articles of association
The company's articles of association in force, certified by the registrador.
Public· Incorporated 2020
Certificate of powers of attorney
Powers in force held by a given apoderado (state their NIF or name).
Public
Certificate of good standing and current officers
Conclusive certificate of existence, good standing and the cargos currently in office.
Public
Certificate of beneficial ownership
The company's official beneficial owners.
Requires a legitimate interest (shareholder, director or obliged entity)
Credit risk report
Commercial credit risk report on the company.
Public
Official documents from Spain's Registro Mercantil · delivered as PDFs. Price set by the official arancel, we send a quote once you request one.
Contact details
Prospect
Spanish companies in the same line of business — Investigación y desarrollo experimental en biotecnología — are listed together.